A jar and scoop of amino-acid powder beside water, a dumbbell, a towel, eggs, soybeans and yogurt.

BCAAs: Muscle, Soreness, Recovery and Clinical Uses

What are BCAAs?

BCAA stands for branched-chain amino acids: leucine, isoleucine and valine. All three are essential amino acids, which means your diet must supply them. The name describes their chemical structure. A BCAA supplement combines these three; an EAA product supplies all nine essential amino acids.

Food and complete protein powders supply BCAAs along with other amino acids; a BCAA supplement supplies just those three.

What BCAAs do in your body

All three become part of proteins your body builds. Muscle can also break them down for energy. Leucine helps activate a signal for muscle-protein building, while the process needs the full set of essential amino acids as material. NIH ODS[1] describes these roles separately from the evidence for taking extra BCAAs.

The supplement question is therefore more specific than whether BCAAs are necessary. It is whether adding a mixture improves muscle growth, soreness, restored strength or another outcome in someone whose food already supplies them.

What people take BCAAs for

Claimed benefit Dose / form studied Research verdict Evidence strength
Build more muscle after training A 5.6 g drink after one resistance session in 10 trained men An acute protein-building measure increased; long-term muscle gain was not tested Review pending
Reduce soreness after strenuous exercise Regimens varied; one trial used 10 g twice daily for 12 days with extra doses around exercise Some trials and a pooled review found less soreness Review pending
Restore strength or exercise performance faster Different BCAA formulas after damaging exercise or repeated hard training A small drop-jump trial was positive for force recovery; a squat-training trial was not Review pending
Support nutrition in advanced cirrhosis Clinical oral BCAA regimens; one trial lasted a year Some clinical benefits were reported, but guidance differs Review pending

The research amounts describe particular experiments. They are not a standard supplement plan, and a recovery study does not establish a muscle-building dose.

How much comes from food?

The National Academies' adult dietary references[2] are 42 mg/kg/day leucine, 19 mg/kg/day isoleucine and 24 mg/kg/day valine. For a 70 kg adult, those are about 2.94 g, 1.33 g and 1.68 g respectively, across the entire diet. Adding them does not create an official BCAA-powder dose or a required 2:1:1 ratio.

Protein foods such as dairy, eggs, fish, meat, tofu and lentils provide all three. The following totals add the three amino-acid values from the same USDA food records[3] used for the individual amino-acid food tables. They are rounded estimates for the stated serving, not a claim that every preparation is identical.

Food and preparation Serving Leucine + isoleucine + valine
Chicken breast, roasted 3 oz, about 85 g 4.68 g
Sockeye salmon, cooked 3 oz, about 85 g 4.18 g
Firm tofu, calcium-set, raw ½ cup, about 126 g 3.92 g
Lentils, boiled 1 cup, about 198 g 2.95 g
Whole milk 1 cup, about 244 g 1.63 g
Egg, hard-boiled 1 large, about 50 g 1.26 g

Food also supplies other nutrients and amino acids. A number on a BCAA label should therefore be compared with what the diet already contributes, rather than treated as a nutrient absent from meals.

How can I tell if I'm low on BCAAs?

Assess the overall protein intake first. Low appetite, a restrictive diet or illness may reduce several essential amino acids together. Food and portion records can help a dietitian estimate intake against dietary requirements; the presence of a protein food alone does not establish adequacy or diagnose a BCAA deficiency.

The trials below did not validate a consumer blood test that tells a healthy person to buy a BCAA product. Inherited disorders of BCAA metabolism involve different tests and specialist diets.

Forms and labels: read the three amounts

In a true 2:1:1 weight ratio, half the BCAA total is leucine, one quarter is isoleucine and one quarter is valine. A 6 g serving therefore supplies 3 g leucine, 1.5 g isoleucine and 1.5 g valine. The recovery trials used different formulas, schedules and exercise tests, so their results cannot identify an ideal ratio.

Read individual ingredient lines when available. An archived NIH label[4] lists 2.3 g leucine and 1.1 g each of isoleucine and valine. That is a label-reading example, not confirmation of a current product or seller.

The scoop's total weight may also include flavors, carbohydrate or other active ingredients. A proprietary blend can prevent you from checking the three amounts. Capsules require the same arithmetic across the full serving, which may contain several capsules.

Common myths about BCAAs

Does less soreness mean more muscle growth?

No. Soreness is an experience after exercise. Muscle size, strength recovery and performance are different measurements. A supplement can improve how sore someone feels without improving the weight they can lift or the muscle they gain over months.

Are BCAAs interchangeable with protein or EAAs?

No. BCAAs supply only three essential amino acids. An EAA mixture includes the other six, while protein foods and many protein powders supply essential and nonessential amino acids together. A favorable BCAA-versus-placebo result does not show that BCAAs outperform a sufficient amount of complete protein.

Drawbacks and side effects

Potential drawback When/who it affects Research evidence Practical implication
Limited evidence for prolonged high intake People repeating large experimental regimens NIH summarizes short-term divided-dose studies up to 20 g/day; this is not an official upper limit Do not turn a short recovery protocol into an indefinite intake target.
Conflict with a prescribed amino-acid diet Maple syrup urine disease and related metabolic disorders The three BCAAs are directly involved in the restricted intake Check every amino-acid product against the specialist plan.
A preparation does not match the clinical purpose People considering BCAAs because of liver-disease research Trials and guidance concern specific clinical nutrition settings Review the formulation and total diet with the liver-care team.

The science behind BCAAs

Muscle building over hours versus months

In the 2017 Jackman trial[5], 10 resistance-trained men received 5.6 g BCAAs or placebo after exercise. Muscle-protein synthesis increased over the next four hours with BCAAs. This showed an acute response, not greater muscle size after a training program.

The experiment did not directly compare BCAAs with whey or test additional long-term muscle gain when dietary protein was already sufficient.

Soreness and restored strength

A 2012 trial by Howatson and colleagues[6] tested 12 trained men using BCAAs or placebo around 100 drop jumps. The regimen supplied 10 g twice daily for 12 days, with additional 20 g doses before and after the exercise. Soreness was lower at 24 and 48 hours. Force loss at 24 hours was about 18% with BCAAs versus 27% with placebo, but vertical-jump recovery did not improve. The authors declared no competing interests. The small sample and unusually large exercise-day intake matter when applying the result.

An earlier trial[7] also found less soreness after damaging exercise but did not show less force loss. A 2024 synthesis of 18 studies[8] found lower self-rated soreness at several points from one to four days after exercise and changes in some muscle-damage markers. It combines earlier trials rather than providing an independent group of new participants. A lower blood marker is not itself better sporting performance.

The result was different in a 2016 trial by Kephart and colleagues[9]. Thirty trained men undertook three demanding squat sessions on consecutive days. Immediately after each session, they took a drink supplying 6 g of the three BCAAs plus 2 g carbohydrate, or a comparison drink with 42 g carbohydrate. They also took their assigned supplement on the following recovery day. Strength recovery and soreness did not improve with BCAAs. This was a comparison with substantially more carbohydrate, rather than a calorie-matched placebo. MusclePharm funded the trial, and one author was an employee.

Taken together, the studies support a possible soreness benefit more clearly than a consistent improvement in restored strength or performance. They do not resolve whether adding BCAAs to an already sufficient protein diet is worthwhile for a particular athlete. The main comparisons above were with placebo or carbohydrate, rather than adequate complete protein.

Why BCAAs appear in cirrhosis care

Cirrhosis research asks a different question from gym supplementation. People may have poor intake, altered amino-acid metabolism and muscle wasting. Liver disease does not mean that all protein or BCAAs must be avoided; the nutrition plan needs to fit the condition. In a year-long trial of 174 people with advanced cirrhosis[10], BCAAs reduced a combined outcome of death or clinical deterioration compared with lactoalbumin, a milk protein. The comparison with maltodextrin, a carbohydrate, did not reach statistical significance. Hospital admissions were lower, while long-term adherence was poor.

A separate 56-week trial[11] enrolled 116 people with cirrhosis after an episode of hepatic encephalopathy, the confusion and other brain symptoms caused by liver disease. It compared 30 g/day BCAAs with maltodextrin while both groups followed a study diet supplying 0.7 g/kg/day protein and 35 kcal/kg/day. That restrictive historical diet is important context, not a general nutrition recommendation for people with cirrhosis. The probability of remaining free of another episode did not differ clearly: 47% with BCAAs versus 34% with maltodextrin. Two thinking tests and upper-arm muscle circumference improved with BCAAs. Those narrower findings should not be described as demonstrated prevention of recurrence.

Guidance is not uniform. The European Society for Clinical Nutrition and Metabolism's 2019 guideline[12] supports oral BCAAs in advanced cirrhosis and in the rare patient who develops liver-related confusion after eating normal amounts of mixed dietary protein. The guideline calls the latter group “protein-intolerant” and gives a clinical BCAA amount of 0.25 g/kg/day. The American Association for the Study of Liver Diseases' 2021 guidance[13] does not recommend long-term BCAA supplementation beyond meeting recommended protein intake through diverse foods.

These are different professional judgments about clinical nutrition evidence. They justify a discussion with the treating team, including the person's intake and tolerance. They do not establish a routine BCAA dose for healthy exercisers or show that an arbitrary sports powder matches a medical preparation.

The bottom line

BCAAs are necessary components of food protein. Extra BCAAs can raise an acute muscle-building measure and may reduce soreness after demanding exercise, but recovery results differ and additional long-term muscle growth beyond sufficient protein remains unestablished. Check the actual three ingredient amounts and distinguish feeling less sore from performing better. Clinical use in cirrhosis has its own evidence and disagreement; it belongs within the person's nutrition care.

Editor's note: For a daily shake, we prefer whey protein as the base because it supplies all nine essential amino acids. We also favor a smaller addition of collagen peptides, or beef isolate with an amino-acid profile similar to collagen, to increase glycine and proline. That is a preference about composition, not a demonstrated advantage for muscle growth. Our whey-and-beef mix article explains the comparison.

Help us improve this article

Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.

Email us directly